Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'docetaxel' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 571 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Simona Ravera; Lorenzo G. Mantovani
      Valutazione dei costi associati alla terapia con taxani nel trattamento adiuvante del carcinoma della mammella in Italia

      Farmeconomia e percorsi terapeutici
    2. Roberto Ravasio
      Analisi di costo di pemetrexed vs docetaxel nel trattamento di seconda linea del carcinoma polmonare non a piccole cellule

      Farmeconomia e percorsi terapeutici
    3. Miyoshi, Y; Ando, A; Takamura, Y; Taguchi, T; Tamaki, T; Noguchi, S
      Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues

      INTERNATIONAL JOURNAL OF CANCER
    4. Buchholz, TA; Hill, BS; Tucker, SL; Frye, DK; Kuerer, HM; Buzdar, AU; McNeese, MD; Singletary, SE; Ueno, NT; Pusztai, L; Valero, V; Hortobagyi, GN
      Factors predictive of outcome in patients with breast cancer refractory toneoadjuvant chemotherapy

      CANCER JOURNAL
    5. Ciccolini, J; Catalin, J; Blachon, MF; Durand, A
      Rapid high-performance liquid chromatographic determination of docetaxel (Taxotere) in plasma using liquid-liquid extraction

      JOURNAL OF CHROMATOGRAPHY B
    6. Gueritte, F
      General and recent aspects of the chemistry and structure-activity relationships of taxoids

      CURRENT PHARMACEUTICAL DESIGN
    7. Harries, M; Kaye, SB
      Recent advances in the treatment of epithelial ovarian cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    8. Brown, RE; Hutton, J; Burrell, A
      Cost effectiveness of treatment options in advanced breast cancer in the UK

      PHARMACOECONOMICS
    9. Rose, WC; Long, BH; Fairchild, CR; Lee, FYF; Kadow, JF
      Preclinical pharmacology of BMS-275183, an orally active taxane

      CLINICAL CANCER RESEARCH
    10. Kaye, SB
      The integration of docetaxel into first-line chemotherapy for ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    11. Calderoni, A; Cerny, T
      Taxanes in lung cancer: a review with focus on the European experience

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    12. Brugnatelli, S; Riccardi, A; Danova, M; Pugliese, P; Tinelli, C; Luchena, G; Bernardo, A; Giardina, G; Fava, S; Montanari, G; Pedrotti, C; Poli, AM
      Sequential docetaxel and vinorelbine for patients with advanced breast cancer previously treated with anthracyclines: A phase II study

      ONCOLOGY REPORTS
    13. Kuroi, K; Tanaka, C; Toi, M
      Clinical significance of plasma nucleosome levels in cancer patients

      INTERNATIONAL JOURNAL OF ONCOLOGY
    14. Sommer, K; Peters, SO; Robins, IH; Raap, M; Wiedemann, GJ; Remmert, S; Sieg, P; Bittner, C; Feyerabend, T
      A preclinical model for experimental chemotherapy of human head and neck cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    15. Mason, K; Staab, A; Hunter, N; McBride, W; Petersen, S; Terry, N; Milas, L
      Enhancement of tumor radioresponse by docetaxel: Involvement of immune system

      INTERNATIONAL JOURNAL OF ONCOLOGY
    16. Kosmas, C; Tsavaris, N; Panopoulos, C; Vadiaka, M; Stavroyianni, N; Kourelis, T; Malamos, N; Antonopoulos, M; Kalofonos, HP
      Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane plus platinum-based regimens

      EUROPEAN JOURNAL OF CANCER
    17. Papakostas, P; Kouroussis, C; Androulakis, N; Samelis, G; Aravantinos, G; Kalbakis, K; Sarra, E; Souglakos, J; Kakolyris, S; Georgoulias, V
      First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study

      EUROPEAN JOURNAL OF CANCER
    18. Oka, M; Fukuda, M; Fukuda, M; Kinoshita, A; Kuba, M; Ichiki, M; Rikimaru, T; Soda, H; Takatani, H; Narasaki, F; Nagashima, S; Nakamura, YI; Hayashi, N; Kohno, S
      Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in unresectable and locally advanced non-small cell lung cancer

      EUROPEAN JOURNAL OF CANCER
    19. Sternberg, CN
      Systemic treatment and new developments in advanced prostate cancer

      EUROPEAN JOURNAL OF CANCER
    20. Takeda, Y; Yoshizaki, I; Nonaka, Y; Yanagie, H; Matsuzawa, A; Eriguchi, M
      Docetaxel alone or orally combined with 5-fluorouracil and its derivatives: effects on mouse mammary tumor cell line MM2 in vitro and in vivo

      ANTI-CANCER DRUGS
    21. Li, N; van Agthoven, M; Willemse, PHB; Uyl-de Groot, CA
      A cost-utility analysis comparing second-line chemotherapy schemes in patients with metastatic breast cancer

      ANTI-CANCER DRUGS
    22. Locker, GJ; Wenzel, C; Schmidinger, M; Gnant, MFX; Marosi, C; Jakesz, R; Zielinski, CC; Steger, GG
      Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancerpatients

      ANTI-CANCER DRUGS
    23. Gandara, DR; Lara, PN; Goldberg, Z; Roberts, P; Lau, DHM
      Neoadjuvant therapy for non-small cell lung cancer

      ANTI-CANCER DRUGS
    24. Green, MR
      The current status of docetaxel for advanced non-small cell lung cancer

      ANTI-CANCER DRUGS
    25. Small, EJ
      Docetaxel in prostate cancer

      ANTI-CANCER DRUGS
    26. Posner, MR
      Docetaxel in squamous cell cancer of the head and neck

      ANTI-CANCER DRUGS
    27. Smith, IC; Miller, ID
      Issues involved in research into the neoadjuvant treatment of breast cancer

      ANTI-CANCER DRUGS
    28. Berghammer, P; Pohnl, R; Baur, M; Dittrich, C
      Docetaxel extravasation

      SUPPORTIVE CARE IN CANCER
    29. Laufman, LR; Spiridonidis, CH; Pritchard, J; Roach, R; Zangmeister, J; Larrimer, N; Moore, T; Segal, M; Jones, J; Patel, T; Gutterman, L; Carman, L; Colborn, D; Kuebler, JP
      Monthly docetaxel and weekly gemcitabine in metastatic breast cancer: A phase II trial

      ANNALS OF ONCOLOGY
    30. Beer, TM; Pierce, WC; Lowe, BA; Henner, WD
      Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer

      ANNALS OF ONCOLOGY
    31. Kostler, WJ; Brodowicz, T; Attems, Y; Hejna, M; Tomek, S; Amann, G; Fiebiger, WCC; Wiltschke, C; Krainer, M; Zielinski, CC
      Docetaxel as rescue medication in anthracycline- and ifosfamide-resistant locally advanced or metastatic soft tissue sarcoma: Results of a phase II trial

      ANNALS OF ONCOLOGY
    32. Marti, JL; Bueso, P; Mayordomo, JI; Isla, MD; Saenz, A; Escudero, P; Murillo, L; Filipovich, E; Andres, R; Tres, A
      Combination chemotherapy with docetaxel plus vinorelbine in metastatic breast cancer patients with prior exposure to anthracyclines

      ANNALS OF ONCOLOGY
    33. Venturini, M; Michelotti, A; Papaldo, P; Del Mastro, L; Bergaglio, M; Lionetto, R; Lunardi, G; Sguotti, C; Frevola, L; Donati, S; Rosso, R; Cognetti, F
      Identification of the highest dose of docetaxel associable with active doses of epirubicin. Results from a dose-finding study in advanced breast cancer patients

      ANNALS OF ONCOLOGY
    34. Campone, M; Fumoleau, P; Delecroix, V; Deporte-Fety, R; Perrocheau, G; Vernillet, L; Borg-Olivier, O; Louboutin, JP; Bissery, MC; Riva, A; Azli, N
      Phase I dose-finding and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer

      ANNALS OF ONCOLOGY
    35. Khuri, FR; Herbst, RS; Fossella, FV
      Emerging therapies in non-small-cell lung cancer

      ANNALS OF ONCOLOGY
    36. Alexopoulos, A; Kouroussis, C; Malamos, N; Kakolyris, S; Kalbakis, K; Kosmas, C; Mavroudis, D; Agelaki, S; Vlachonicolis, J; Sarra, E; Rigatos, G; Georgoulias, V
      Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: A multicenter phase II study

      ANNALS OF ONCOLOGY
    37. Kornblith, AB; Herndon, JE; Zuckerman, E; Godley, PA; Savarese, D; Vogelzang, NJ; Holland, JC
      The impact of docetaxel, estramustine, and low dose hydrocortisone on the quality of life of men with hormone refractory prostate cancer and their partners: A feasibility study

      ANNALS OF ONCOLOGY
    38. Caponigro, F; Massa, E; Manzione, L; Rosati, G; Biglietto, M; De Lucia, L; Sguotti, C; Sganga, P; Avallone, A; Comella, P; Mantovani, G; Comella, G
      Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: A phase II study of the Southern Italy Cooperative Oncology Group (SICOG)

      ANNALS OF ONCOLOGY
    39. Stemmler, HJ; Gutschow, K; Sommer, H; Malekmohammadi, M; Kentenich, C; Forstpointner, R; Geuenich, S; Bischoff, J; Hiddemann, W; Heinemann, V
      Weekly docetaxel (Taxotere (R)) in patients with metastatic breast cancer

      ANNALS OF ONCOLOGY
    40. Ridwelski, K; Gebauer, T; Fahlke, J; Kroning, H; Kettner, E; Meyer, F; Eichelmann, K; Lippert, H
      Combination chemotherapy with docetaxel and cisplatin for locally advancedand metastatic gastric cancer

      ANNALS OF ONCOLOGY
    41. Spiridonidis, CH; Laufman, LR; Carman, L; Moore, T; Blair, S; Jones, J; George, C; Patel, T; Roach, R; Rupert, R; Zangmeister, J; Colborn, D; Kuebler, JP
      Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: A phase II trial

      ANNALS OF ONCOLOGY
    42. Stathopoulos, GP; Mavroudis, D; Tsavaris, N; Kouroussis, C; Aravantinos, G; Agelaki, S; Kakolyris, S; Rigatos, SK; Karabekios, S; Georgoulias, V
      Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: A phase II study of the Greek Cooperative Group for Pancreatic Cancer

      ANNALS OF ONCOLOGY
    43. Bell, R
      Ongoing trials with trastuzumab in metastatic breast cancer

      ANNALS OF ONCOLOGY
    44. Hamilton, A; Muggia, F
      Estramustine potentiates taxane in prostate and refractory breast cancers

      ONCOLOGY-NEW YORK
    45. Natale, RB
      Gemcitabine and nonplatinum combinations in non-small-cell Lung cancer

      ONCOLOGY-NEW YORK
    46. Manegold, C
      Treatment of elderly patients with non-small-cell lung cancer

      ONCOLOGY-NEW YORK
    47. Georgoulias, VA
      Docetaxel/gemcitabine: Salvage chemotherapy in anthracycline-pretreated patients with advanced breast cancer

      ONCOLOGY-NEW YORK
    48. Leu, KM; Zalupski, MM
      Chemotherapy for resectable and advanced pancreatic cancer - The Berlin/Rothenberg article reviewed

      ONCOLOGY-NEW YORK
    49. Kastrissios, H; Ratain, MJ
      Screening for sources of interindividual pharmacokinetic variability in anticancer drug therapy: Utility of population analysis

      CANCER INVESTIGATION
    50. Hidalgo, M; Aylesworth, C; Hammond, LA; Britten, CD; Weiss, G; Stephenson, J; Schwartz, G; Patnaik, A; Smith, L; Molpus, K; Felton, S; Gupta, E; Ferrante, KJ; Tortora, A; Sonnichsen, DS; Skillings, J; Rowinsky, EK
      Phase I and pharmacokinetic study of BMS-184476, a taxane with greater potency and solubility than paclitaxel

      JOURNAL OF CLINICAL ONCOLOGY
    51. Grasselli, G; Vigano, L; Capri, G; Locatelli, A; Tarenzi, E; Spreafico, C; Bertuzzi, A; Giani, A; Materazzo, C; Cresta, S; Perotti, A; Valagussa, P; Gianni, L
      Clinical and pharmacologic study of the epirubicin and paclitaxel combination in women with metastatic breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    52. Jassem, J; Pienkowski, T; Pluzanska, A; Jelic, S; Gorbunova, V; Mrsic-Krmpotic, Z; Berzins, J; Nagykalnai, T; Wigler, N; Renard, J; Munier, S; Weil, C
      Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: Final results of a randomized phase III multicenter trial

      JOURNAL OF CLINICAL ONCOLOGY
    53. Taamma, A; Misset, JL; Riofrio, M; Guzman, C; Brain, E; Lazaro, LL; Rosing, H; Jimeno, JM; Cvitkovic, E
      Phase I and pharmacokinetic study of ecteinaseidin-743, a new marine compound, administered as a 24-hour continuous infusion in patients with solid tumors

      JOURNAL OF CLINICAL ONCOLOGY
    54. Isla, D; Rosell, R; Sanchez, JJ; Carrato, A; Felip, E; Camps, C; Artal, A; Gonzalez-Larriba, JL; Azagra, P; Alberola, J; Martin, C; Massuti, B
      Phase II trial of paclitaxel plus gemcitabine in patients with locally advanced or metastatic non-small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    55. de Jongh, FE; Verweij, J; Loos, WJ; de Wit, R; de Jonge, MJA; Planting, AST; Nooter, K; Stoter, G; Sparreboom, A
      Body-surface area-based dosing does not increase accuracy of predicting cisplatin exposure

      JOURNAL OF CLINICAL ONCOLOGY
    56. Jassem, J
      Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide for metastatic breast cancer - In reply

      JOURNAL OF CLINICAL ONCOLOGY
    57. Kelly, WK; Curley, T; Slovin, S; Heller, G; McCaffrey, J; Bajorin, D; Ciolino, A; Regan, K; Schwartz, M; Kantoff, P; George, D; Oh, W; Smith, M; Kaufman, D; Small, EJ; Schwartz, L; Larson, S; Tong, W; Scher, H
      Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer

      JOURNAL OF CLINICAL ONCOLOGY
    58. Perez-Calvo, J; Fernandez-Hidalgo, O; Subira, ML; Martin-Algarra, S; Salgado, E; Brugarolas, A
      Mobilization of hematopoietic progenitor cells with a combination of docetaxel, adriamycin, 5-fluorouracil and filgrastim in breast cancer patients

      HAEMATOLOGICA
    59. Mandai, T; Okumoto, H; Oshitari, T; Nakanishi, K; Mikuni, K; Hara, KJ; Hara, KZ; Iwatani, W; Amano, T; Nakamura, K; Tsuchiya, Y
      Synthesis and biological evaluation of water soluble taxoids bearing sugarmoieties

      HETEROCYCLES
    60. Inoue, A; Saijo, N
      Recent advances in the chemotherapy of non-small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    61. Ohe, Y; Niho, S; Kakinuma, R; Kubota, K; Matsumoto, T; Ohmatsu, H; Goto, K; Kunitoh, H; Saijo, N; Nishiwaki, Y
      Phase I studies of cisplatin and docetaxel administered by three consecutive weekly infusions for advanced non-small cell lung cancer in elderly and non-elderly patients

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    62. Tai, CJ; Wang, WS; Liu, JH; Yen, CC; Fan, FS; Chiou, TJ; Chen, PM
      Salvage therapy with single-agent paclitaxel by three-hour infusion in metastatic breast cancer: an experience in Taipei Veterans General Hospital

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    63. Colevas, AD; Read, R; Thornhill, J; Adak, S; Tishler, R; Busse, P; Li, Y; Posner, M
      Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    64. Mukohara, T; Takeda, K; Miyazaki, M; Takifuji, N; Terakawa, K; Negoro, S
      Japanese experience with second-line chemotherapy with low-dose (60 mg/m(2)) docetaxel in patients with advanced non-small-cell lung cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    65. Yamamoto, S; Kurebayashi, J; Kurosumi, M; Kunisue, H; Otsuki, T; Tanaka, K; Sonoo, H
      Combined effects of docetaxel and fluoropyrimidines on tumor growth and expression of interleukin-6 and thymidine phosphorylase in breast cancer xenografts

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    66. Bhargava, P; Marshall, JL; Fried, K; Williams, M; Lefebvre, P; Dahut, W; Hanfelt, J; Gehan, E; Figuera, M; Hawkins, MJ; Rizvi, NA
      Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    67. Nallani, SC; Genter, MB; Desai, PB
      Increased activity of CYP3A enzyme in primary cultures of rat hepatocytes treated with docetaxel: comparative evaluation with paclitaxel

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    68. Fujitaka, K; Oguri, T; Isobe, T; Fujiwara, Y; Kohno, N
      Induction of cytochrome P450 3A4 by docetaxel in peripheral mononuclear cells and its expression in lung cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    69. van Zuylen, L; Karlsson, MO; Verweij, J; Brouwer, E; de Bruijn, P; Nooter, K; Stoter, G; Sparreboom, A
      Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    70. Ferrazzi, E; Toso, S; Zanotti, M; Giuliano, G
      Typhlitis (neutropenic enterocolitis) after a single dose of vinorelbine

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    71. Schmidinger, M; Budinsky, AC; Wenzel, C; Locker, GJ; Pluschnig, U; Brodowicz, T; Kubista, E; Maca, S; Zabernigg, A; Ilsinger, P; Seewann, L; Hojas, S; Blach, M; Zielinski, CC; Steger, GG
      Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trial

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    72. Hakamies-Blomqvist, L; Luoma, ML; Sjostrom, J; Pluzanska, A; Sjodin, M; Mouridsen, H; Ostenstad, B; Mjaaland, I; Ottosson, S; Bergh, J; Malmstrom, PO; Blomqvist, C
      Timing of quality of life (QoL) assessments as a source of error in oncological trials

      JOURNAL OF ADVANCED NURSING
    73. Baker, AF; Dorr, RT
      Drug interactions with the taxanes: clinical implications

      CANCER TREATMENT REVIEWS
    74. Baltali, E; Ozisik, Y; Guler, N; Firat, D; Altundag, K
      Combination of docetaxel and doxorubicin as first-line chemotherapy in metastatic breast cancer

      TUMORI
    75. Viens, P; Roche, H; Kerbrat, P; Fumoleau, P; Guastalla, JP; Delozier, T
      Epirubicin-docetaxel combination in first-line chemotherapy for patients with metastatic breast cancer - Final results of a dose-finding and efficacystudy

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    76. Janinis, J; Papadakou, M; Panagos, G; Panousaki, A; Georgoulias, V; Hatzidaki, D; Lefantzis, D; Dokianakis, G
      Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracilin patients with locally advanced head and neck cancer

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    77. Milla-Santos, A; Rallo, L; Solano, V
      High-dose epirubicin plus docetaxel at standard dose with lenograstim support as first-line therapy in advanced breast cancer

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    78. Lanzi, C; Cassinelli, G; Cuccuru, G; Supino, R; Zuco, V; Ferlini, C; Scambia, G; Zunino, F
      Cell cycle checkpoint efficiency and cellular response to paclitaxel in prostate cancer cells

      PROSTATE
    79. Laport, GG; Fleming, GF; Waggoner, S; Zimmerman, TM; Grinblatt, DL; Williams, SF
      A phase II trial of docetaxel for peripheral blood stem cell mobilization for patients with breast cancer and ovarian cancer

      BONE MARROW TRANSPLANTATION
    80. Mileshkin, L; Prince, HM; Rischin, D; Zimet, A
      Severe interstitial pneumonitis following high-dose cyclophosphamide, thiotepa and docetaxel: two case reports and a review of the literature

      BONE MARROW TRANSPLANTATION
    81. Ridwelski, K; Meyer, F
      Current options for palliative treatment in patients with pancreatic cancer

      DIGESTIVE DISEASES
    82. Pectasides, D; Kalofonos, HP; Samantas, E; Nicolaides, C; Papacostas, P; Onyenadum, A; Visvikis, A; Skarlos, D; Fountzilas, G
      An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic Co-Operative Oncology Group

      ANTICANCER RESEARCH
    83. Kubota, T; Egawa, T; Furukawa, T; Otani, Y; Watanabe, M; Furukawa, T; Kumai, K
      Docetaxel enhances the cytotoxicity of tetrahydropyranyladriamycin in a sequence-dependent manner

      ANTICANCER RESEARCH
    84. Bobkov, K; Gut, I; Mandys, V; Holy, A; Votruba, I; Otova, B
      Antitumour activity of a combined treatment with PMEDAP and docetaxel in the Prague inbred Sprague-Dawley/Cub rat strain bearing T-cell lymphoma

      ANTICANCER RESEARCH
    85. Bando, H; Miyata, J; Sano, T; Sumitomo, M
      Retrospective analysis of administration of a combination of docetaxel andcarboplatin for advanced non-small cell lung cancer

      ANTICANCER RESEARCH
    86. Meden, H; Beneke, A; Hesse, T; Novophashenny, I; Wischnewsky, M
      Weekly intravenous recombinant humanized anti-P185(HER2) monoclonal antibody (herceptin) plus docetaxel in patients with metastatic breast cancer: A pilot study

      ANTICANCER RESEARCH
    87. De Rosa, L; Lalle, M; Perillo, A; Pierelli, L; Salerno, MG; Cortesi, E; Martelli, O; Pandolfi, A; Amodeo, R; Marzetti, L; Mancuso, S; Scambia, G
      Docetaxel and epirubicin plus G-CSF as mobilizing treatment to support high-dose chemotherapy in breast cancer

      ANTICANCER RESEARCH
    88. Cardoso, F; Ferreira, AF; Crown, J; Dolci, S; Paesmans, M; Riva, A; Di Leo, A; Piccart, MJ
      Doxorubicin followed by docetaxel versus docetaxel followed by doxorubicinin the adjuvant treatment of node positive breast cancer: Results of a feasibility study

      ANTICANCER RESEARCH
    89. Agiostratidou, G; Sgouros, I; Galani, E; Voulgari, A; Chondrogianni, N; Samantas, E; Dimopoulos, MA; Skarlos, D; Gonos, ES
      Correlation of in vitro cytotoxicity and clinical response to chemotherapyin ovarian and breast cancer patients

      ANTICANCER RESEARCH
    90. Giesel, BU; Kutz, GG; Thiel, HJ
      Recall dermatitis caused by reexposition of Docetaxel following irradiation of the brain. Case report and review of literature

      STRAHLENTHERAPIE UND ONKOLOGIE
    91. Leu, KM; Kim, KM; Larson, M; Larson, M; Schiller, JH
      Phase I/II trial of docetaxel and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy

      LUNG CANCER
    92. Koizumi, T; Tsunoda, T; Fujimoto, K; Nomura, H; Hirai, K; Koyama, S; Okada, K; Kubo, K
      Phase I trial of weekly docetaxel combined with cisplatin in patients withnon-small cell lung cancer

      LUNG CANCER
    93. Kunitoh, H; Akiyama, Y; Kusaba, H; Yamamoto, N; Sekine, I; Ohe, Y; Kubota, K; Tamura, T; Shinkai, T; Kodama, T; Goto, K; Niho, S; Nishiwaki, Y; Saijo, N
      A phase I/II trial of cisplatin, docetaxel and ifosfamide in advanced or recurrent non-small cell lung cancer

      LUNG CANCER
    94. Rebattu, P; Quantin, X; Ardiet, C; Morere, JF; Azarian, MR; Schuller-Lebeau, MP; Pujol, JL
      Dose-finding, pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patients with inoperable non-small cell lung cancer

      LUNG CANCER
    95. van Putten, JWG; Baas, P; Codrington, H; Kwa, HB; Muller, M; Aaronson, N; Groen, HJM
      Activity of single-agent gemcitabine as second-line treatment after previous chemotherapy or radiotherapy in advanced non-small-cell lung cancer

      LUNG CANCER
    96. Sato, K; Tsuchiya, S; Minato, K; Takei, Y; Watanabe, S; Saitoh, R; Mori, M
      A phase I study of weekly docetaxel and cisplatin in advanced non-small cell lung cancer

      LUNG CANCER
    97. Zarogoulidis, K; Kontakiotis, T; Hatziapostolou, P; Fachantidou, E; Delis, D; Goutsikas, J; Constantinidis, TC; Athanasiadis, A; Patakas, D
      A phase II study of docetaxel and carboplatin in the treatment of non-small cell lung cancer

      LUNG CANCER
    98. Kakolyris, S; Papadakis, E; Tsiafaki, X; Kalofonos, C; Rapti, A; Toubis, M; Bania, E; Kouroussis, C; Chainis, K; Androulakis, N; Agelaki, S; Sarra, E; Vardakis, N; Georgoulias, V
      Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study

      LUNG CANCER
    99. van Zuylen, L; Verweij, J; Sparreboom, A
      Role of formulation vehicles in taxane pharmacology

      INVESTIGATIONAL NEW DRUGS
    100. Nuijen, B; Bouma, M; Schellens, JHM; Beijnen, JH
      Progress in the development of alternative pharmaceutical formulations of taxanes

      INVESTIGATIONAL NEW DRUGS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 23:17:55